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The immune responsiveness of guinea pigs to the synthetic antigen GT,  1 a random 
linear copolymer of z-glutamic acid and L-tyrosine,  is determined by the presence of 
a unigenic autosomal dominant mendellian trait designated the "GT gene." This gene 
is expressed  in all inbred strain 13 guinea pigs and in a variable percentage of random- 
bred Hartley guinea pigs, but it is totally lacking in inbred strain 2 guinea pigs. Those 
animals having the  GT gene respond to  GT immunization with both cellular and 
humoral immunity and are thus termed "responders." "Nonresponders" lack the gene 
and make no detectable immune response after GT immunization (1, 2). 
The backcross  progeny resulting from mating GT responder (2  X  13)F~ guinea pigs 
to  nonresponder strain 2 animals segregate  in a  1:1  ratio  of responders  to  nonre- 
sponders.  Among these  backcross  animals, linkage between  the  GT gene  and the 
genetic locus coding for major strain 13 histocompatibility  antigens was demonstrated 
by showing the presence of these strain  13 histocompatibility specificities  only on the 
cells from GT responders (2). 
The linkage between specific immune response genes and histocompatibitity geno- 
types has been demonstrated previously in both guinea pigs  and mice and may be 
considered a general phenomenon. The GT gene is similar in behavior to the-poly-z- 
lysine (PLL)  gene which is linked to the genes coding for major strain 2 histocom- 
patibility specificities  in guinea pigs (3, 4)  and to the genes at the Ir-1 locus in mice 
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which  are linked  to  the H-2 histocompatibility  locus  (5).  In all of  these  studies  no 
animals  were  found  in  which  expression  of  the  immune  response  gene  and  the  ap- 
propriate  histocompatibility  genotype  was  not  associated.  The  possibility  must  be 
seriously considered that  immune response genes may be identical with genes coding 
for certain histocompatibility  specificities. In previous experiments,  the presence  of 
major strain 2 histocompatibility specificities on cells of 94 random-bred  guinea pigs 
from various sources was always associated with the possession of the PLL gene (4). 
The  inseparability  of  the  PLL gene and  the  genes coding for major  strain  2  histo- 
compatibility specificities in these random-bred  guinea pigs, among whom detectable 
"crossing-over" would have been expected after the many years of random breeding, 
may be considered strong evidence for a  single genetic locus controlling both charac- 
teristics. 
In the present  study we report  on the relationship  between immune respon- 
siveness  to  GT  and  the  expression  of strain  13  histocompatibility  specificities 
among random-bred  guinea pigs. We demonstrate  the presence of two distinct 
major  histocompatibility  specificities  in  these  animals  detected  by  strain  2 
anti-strain  13  isoantisera.  One  of  these  specificities is  linked  to  the  GT  gene 
and  the other is not. 
Materials and Methods 
Animals.--Hartley  guinea  pigs,  an  albino  random-bred  strain,  and  NIH  multipurpose 
guinea pigs,  a  pigmented  random-bred  strain,  were obtained  from the Animal Production 
Unit, National Institutes of Health, Bethesda,  Md. All animals used in this study weighed 
between 250 and 350 g when immunized. 
Reagents.--Poly-o~-(L-glutamic acid  [50%],  I~-tyrosine  [50%]),  GT,  tool wt  14,500, was 
obtained from Miles Laboratories, Inc., Elkhart, Ind. Complete Freund's adjuvant containing 
0.5  #g/ml Mycobacterium butyricum was  obtained  from Difco Laboratories,  Detroit,  Mich. 
51Cr, 185 #Ci/pg, was obtained from Amersham-Searle, Chicago, Ill. 
Determination of Responder Status.--A  solution of GT in saline was  emulsified with  an 
equal volume of complete Freund's adjuvant. The concentration was adjusted so that  each 
guinea pig received 500 #g of GT in 0.4 ml of emulsion distributed evenly in the four footpads. 
3 wk after immunization, the animals were tested with 50/zg of GT in 0.1 ml saline injected 
intradermally, The skin  tests, examined 24 hr later, were considered positive if the erythema 
and  induration  significantly  exceeded  the  largest  nonspecific  irritation  observed  in  non- 
immunized controls. There were no equivocal reactions. Those animals demonstrating positive 
skin tests were considered responders.  This correlated perfectly with their capacity to form 
anti-GT antibodies demonstrable by the Farr-type assay described previously (1). 
Preparation of Antihistocompatibility Antisera.--Strain  2 anti-strain  13 antisera were pro- 
duced as described previously (3). Briefly, strain 2 guinea pigs were immunized with homoge- 
nares of lymph node and spleen cells from strain 13 animals emulsified  in complete Freund's 
adjuvant. Subsequently the animals were boosted every 2 wk with intradermal injections of 
homogenates of strain 13 lymphoid cells emulsified with incomplete adjuvant. The sera used 
in these studies were obtained 8-10 wk after the initial immunization. 
The  sera  were heat  inactivated  at  56°C  for 30  rain.  For  absorption  studies,  the  heat- 
inactivated sera were diluted fivefold and mixed with spleen and  lymph node cells obtained 
from the appropriate  animals,  in a  ratio of 3  ml diluted  serum to  1 ml packed  cells.  The 
mixture was incubated at 37°C for 30 rain after which the cells were removed by centrifugation. 1540  HISTOCOMPATIBILITY-LINKED  GT  GENE  IN  RANDOM :BREDS 
This absorption procedure was  repeated  until the antiserum was  no longer cytotoxic to an 
aliquot  of  the  cell  population  used  for  the  absorption. 
alCr Cytotoxicity  Test.--Cells from the popliteal or axillary lymph nodes of each animal 
were labeled with atCr as described previously  (4)  and tested for susceptibility to cytolysis 
with the strain 2  anti-strain 13  antisera in the presence of complement. One  million  51Cr- 
labeled lymph node cells were mixed with a 1/i5 final dilution of the antiserum and a }6 final 
dilution of lyophilized guinea pig serum as a  source of complement in a  total volume of 0.3 
ml of L-15 medium containing 10% fetal calf serum. After incubation of the mixture at 37°C 
for 60 min, 0.7 ml of the cold medium was added to each sample and the tubes centrifuged at 
2500 rpm for 10 min in the cold. The radioactivity in 0.5 ml of the supernatant was counted 
and compared with the radioactivity present in an equal volume of supernatants from samples 
containing cells incubated in medium with complement only, and with that present in tubes 
containing cells  frozen  and  thawed four  times.  The percentage of maximum  :~ler released 
TABLE  I 
Linkage  between the GT Gene and the Locus Coding for One of the Major Strain 13 
Histocompatibility  Specificities in Hartley Guinea Pigs 
Per cent release 5lCr* 
GT status  No. of animals 
Unabsorbed serum  Absorbed serum 
% 
Responder  25  56.1{  43.3 
(42.8  75.7)  (27.8-60.9) 
Nonresponder type I  8  0.84  0 
(0-2.6)  (0-0) 
Nonresponder type I[  4  35.8  2.4 
(18.5  43.0)  (0-5.8) 
* The per cent  '~lCr released by a  1:5 dilution of a  strain 2 anti-strain 13 isoantiserum 
(unabsorbed serum) or by the same serum absorbed with spleen and lymph node cells from 
one of the type II GT nonresponders. Details of the absorption procedure and the assay are 
presented in Materials and Methods. 
:~ Value expressed is the mean. The range is in parentheses. 
specifically from the cells of each animal was calculated as follows: 
Per cent release = 
,  [  cpm released by antiserum -- cpm released in absence of antiserum  "~ 
100  ,x, ~kcp  m released t),~'  frozen-thawed~cel---ls  --~ cp~ rel~as--ed i~ absentee of antiserum]" 
RESULTS 
When lymph node cells from Hartley guinea pigs were tested for the presence 
of  strain  13  histocompatibility  specificities,  the  cells  from  all  GT  responders 
were lysed by strain 2  anti-strain  13  antisera  (Table I). Two-thirds  of the GT 
nonresponders, designated as "type I," did not have detectable strain 13 histo- 
compatibility  antigens  on  their cells.  However,  the cells from 4  of  12  Hartley 
GT  nonresponders,  designated  as  "type  II,"  were  lysed  by the anti-strain  13 H.  G.  BLUESTEIN,  I.  GREEN~  AND  B.  BENACERRAF  1541 
antiserum. The mean per cent 51Cr released from the cells of the four type II 
GT nonresponders was only 35.8 % compared to a mean of 56.1% aCr released 
from the  cells of GT responders,  indicating  that  these  type  II nonresponder 
guinea pigs lacked some strain 13 specificity present in  GT responders. Absorp- 
tion  of the  anti-strain  13  antiserum with  cells  obtained from a  type II GT 
nonresponder  animal  rendered  the  antiserum  noncytotoxic  to  cells  obtained 
from all GT nonresponders. Thus, the mean per cent 5tCr released by the anti- 
serum from cells of the four type II nonresponders  expressing some strain  13 
histocompatibility specificity decreased from 35.8 to 2.4 % after the absorption. 
However, the absorbed antiserum retained its specific cytolytic activity against 
cells from all GT responder animals. The mean per cent 51Cr released from the 
cells of GT responders decreased slightly from 56.1  to 43.3 %. Thus  there are 
TABLE II 
Linkage between the GT Gene and the Locus Coding for One of the Major Strain  13 
Histocompatibility Specificities in NIH Multipurpose Guinea Pigs 
GT status  No. of animals 
Per cent release ~lCr* 
Unabsorbed  serum  Absorbed  serum 
% 
Responder  11  46.95  28.1 
(43.1-54.8)  (18.0-37.3) 
Nonresponder  5  42.8  3.2 
(39.8-48.1)  (0-7.2) 
* The per cent 51Cr released by a 1:5 dilution of a strain 2 anti-strain  13 isoantiserum 
(unabsorbed serum) or by a 1:5 dilution of the same serum absorbed with spleen and lymph 
node cells obtained from GT nonresponders as described in Materials and Methods. 
:~ Value expressed is the mean. The range is in parentheses. 
at least two major histocompatibility specificities expressed on cells of Hartley 
guinea pigs that are recognized by the strain 2 anti-strain  13 antiserum. The 
genetic locus controlling the expression of only one of the strain 13 histocom- 
patibility specificities is linked to the GT gene, while the other is not. 
The results of a similar experiment using NIH multipurpose guinea pigs were 
a little different. The lymph node cells from all NIH multipurpose guinea pigs 
tested,  both  GT responders  and  nonresponders,  were lysed by strain  2  anti- 
strain 13 isoantisera in the presence of complement (Table II). There was no 
significant difference in the percentage release of 51Cr between the responders 
and nonresponders. Absorption of the antiserum with spleen and lymph node 
cells obtained from GT nonresponder animals rendered it noncytotoxic to cells 
from all other GT nonresponders. Thus, absorption of the anti-strain  13 anti- 
serum decreased the mean per cent 51Cr that it released from cells of GT non- 
responder guinea pigs from 42.8  to 3.2 %.  However,  the  absorbed  antiserum 1542  HISTOCOMPATIBILITY-LINKED GT  GENE  IN  RANDOM  BREDS 
retained  its  cytolytic activity  against  cells  obtained  from all  GT responder 
animals,  although the per cent 51Cr released was decreased. Absorption of the 
serum  caused  the  mean per  cent  51Cr released  to drop from 46.9  to  28.1%. 
Absorption of the anti-strain  13 antiserum with spleen and lymph node cells 
from GT responder animals renders the antiserum noncytoxic to cells from both 
GT responders and nonresponders as well as to cells from strain 13 guinea pigs. 
Thus, it appears that on the cells of NIH multipurpose guinea pigs at least two 
histocompatibility specificities are expressed that are recognized by the strain 
2 anti-strain  13 antiserum. As in random-bred Hartley guinea pigs,  the gene 
coding for one of those specificities is linked to the GT gene. 
DISCUSSION 
Using two isoantisera prepared in inbred strain 2 guinea pigs directed against 
the histocompatibility antigens present on the cells of strain 13 guinea pigs, we 
have demonstrated  that  at least two different histocompatibility specificities 
that are identical with or highly cross-reactive with major strain 13 antigens are 
expressed on the cells of random-bred guinea pigs. Both anti-13 isoantisera be- 
haved identically and detected both specificities. One of those specificities is 
found only on cells of GT responder guinea pig. Thus, the genetic locus con- 
trolling the expression of that specificity could not be dissociated from the GT 
gene. Among  the  53  random-bred animals  tested,  no animals  were found in 
which the two genes did not occur together. The relationship between the GT 
gene and the strain  13 histocompatibility locus to which it is linked, like the 
relationship between the PLL gene and the strain 2 histocompatibility locus to 
which it is linked  (4), is very intimate.  The absolute association of imnmne 
responsiveness with a particular histocompatibility specificity in both the GT 
and PLL systems strongly suggests that a single genetic locus controls the ex- 
pression of both characteristics. 
The expression of each of the strain 13 histocompatibility specificities is most 
probably controlled by separate genetic loci. However, from our study of the 
backcross progeny from the mating of GT responder (2  X  13)F1 guinea pigs 
with nonresponder strain 2 animals, we know that all the strain 13  histocom- 
patibility specificities detectable by strain 2 isoantisera are inherited  together 
with GT responsiveness (2). The cells of the GT nonresponder backcross animals 
were not susceptible to cytolysis by the  strain  2 anti-strain  13 antisera used 
in this study. Thus it would appear that in the guinea pig as in man and in  the 
mouse  there  are  two  separate  genetic  subloci  controlling the  expression  of 
major  histocompatibility  specificities  which  are  both  located  on  the  same 
chromosome. This interpretation is given strong support by the finding that 
in  some  random-bred Hartley and NIH multipurpose guinea pigs,  only one 
of the  two strain  13 specificities is detected.  This situation  which is  not  in- 
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and man, have resulted from crossing over between the two postulated guinea 
pig subloci. However, our data do not rule out the possibility that the two spec- 
ificities recognized by the anti-strain 13 antisera are directed at different anti- 
genic determinants  on the  same  molecule.  A single  genetic locus  controlling 
both GT responsiveness and the expression of strain 13 histocompatibility spec- 
ificities could conceivably have mutated so that the expression of GT respon- 
siveness and  of only one of the histocompatibility specificities is lost.  How- 
ever, this is the less likely of the two possibilities. 
The two species in which the genetics of histocompatibility specificities has 
been most extensively studied has been the human and the mouse. In both the 
HL-A  system of man and the H-2 system of mice, there are two major histo- 
compatibility  subloci  located  on  the  same  chromosome.  In  the  mouse  the 
immune  response  genes  at  the  [r-1  locus  have  been  mapped  within  the  K 
region of the H-2  locus,  and  the possibility has not yet been ruled out that 
they are identical with factors controlling individual specificities in this region3 
The demonstration in strain  13  guinea pigs of two major histocompatibility 
specificities whose  controlling genes  are  on  the  same  chromosome indicates 
that  the genetics of histocompatibility antigens in guinea pigs may be  anal- 
ogous to the HL-A  and H-2 systems. Furthermore, the finding  that  the  GT 
gene is associated with only one of these specificities is very analogous to the 
demonstrated  association  of Ir-1  with  the  K  region  of the  H-2  locus,  illus- 
trating another characteristic shared by guinea pig and mouse histocompatibly 
linked immune response genes. 
SUMMARY 
The lymph node cells from all L-glutamic acid and L-tyrosine (GT) responder 
random-bred guinea pigs were susceptible to lysis by strain  2  anti-strain  13 
isoantisera in the presence of complement. These same antisera were cytolytic 
for lymph node cells of only some of the GT nonresponder animals. However, 
after  absorption  with  cells,  from  a  nonresponder  guinea  pig,  susceptible  to 
lysis, the anti-strain 13 antisera were no longer able to lyse cells from any GT 
nonresponder guinea  pigs  while retaining  a  large  measure  of  their  cytolytic 
activity for cells of all  GT responder guinea pigs.  Thus,  at least  two major 
strain  13 histocompatibility specificities are expressed on the cells of random- 
bred guinea pigs.  The genetic locus controlling the  expression of only one of 
those  strain  13  histocompatibility specificities is  linked  to  the  GT  immune 
response gene. 
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